Report cover image

Synthetic Biology Market by Tools (DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools), Technology (Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly), End-Use - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 186 Pages
SKU # IRE18450887

Description

Synthetic Biology Market by Tools (DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools), Technology (Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly), End-Use - Global Forecast 2024-2030


The Synthetic Biology Market size was estimated at USD 13.88 billion in 2023 and expected to reach USD 16.61 billion in 2024, at a CAGR 21.33% to reach USD 53.76 billion by 2030.

Global Synthetic Biology MarketSynthetic biology focuses on applying engineering principles to develop new biological parts, devices, and systems or redesign existing systems found in nature. Synthetic biology incorporates many scientific techniques and approaches to create fully operational biological systems from the smallest constituent parts possible, including DNA, proteins, and other organic molecules. The prevalence of chronic diseases and the need for efficient diagnosis are accelerating the use of synthetic biology for novel drug and vaccine development and innovative point-of-care diagnostics devices. However, hazards and risks associated with synthetic biology technology may limit their use by the end-use industries. Moreover, advancements in gene editing, next-generation sequencing, ongoing research, and significant investments to increase the application of synthetic biology across various end-use sectors are expected to encourage the growth of the synthetic biology market.

Regional Insights

The synthetic biology market is highly evolving across the Americas owing to the growing adoption of synthetic biology in the medical and agricultural sectors, rising investments in genomics and proteomics, and the surging development of improved medical devices using synthetic biology technology. Increasing chronic disease cases and rising emphasis on drug discovery & development are expanding the usage of synthetic biology applications in the APAC region. Moreover, government initiatives and programs to accelerate the use and expand research activities in the synthetic biology field are creating significant potential for the growth of the synthetic biology market in the EMEA region. Additionally, ongoing collaborations and partnership activities, along with the integration of breakthrough technologies for developing cutting-edge devices and technologies to increase their use across various industrial verticals, are expected to encourage the growth of the synthetic biology market worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Synthetic Biology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Synthetic Biology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Synthetic Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Batavia Biosciences B.V., Beam Therapeutics, Beckman Coulter, Inc., BGI Genomics Co., Ltd., Codexis, Inc., Conagen, Inc., Creative Enzymes, DNA TwoPointO Inc., Editas Medicine, Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs GmbH, Novozymes A/S, Precigen, Inc., QIAGEN N.V., Sangamo Therapeutics, Scarab Genomics, LLC, Synlogic, Synthego Corporation, TeselaGen Service, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Synthetic Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Tools
DNA Tools
General Tools
Mathematical Modelling & Computer-aided Design Tools
Protein Tools
RNA Tools
Technology
Bioinformatics
Cell Sequencing
Cell Synthesis & Assembly
Cloning
Microfluidics
Nanotechnology
Omics Technologies
Site-directed Mutagenesis
End-Use
Agriculture
Cosmetics & Personal Care
Energy & Natural Resources
Environment
Bioremediation

Biosensing
Food & Beverage
Healthcare & Pharmaceuticals
Artificial Tissue & Tissue Regeneration

Drug Discovery & Therapeutics
Paper & Textile
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Synthetic Biology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Synthetic Biology Market?
3. What are the technology trends and regulatory frameworks in the Synthetic Biology Market?
4. What is the market share of the leading vendors in the Synthetic Biology Market?
5. Which modes and strategic moves are suitable for entering the Synthetic Biology Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

186 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Synthetic Biology Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use for novel drug and vaccines development
5.1.1.2. Expansion of synthetic biology based point-of-care diagnostics devices
5.1.1.3. Accelerating demand for synthetic biology in various industrial applications
5.1.2. Restraints
5.1.2.1. Risks associated with the use of synthetic biology technology
5.1.3. Opportunities
5.1.3.1. Technological advancements in gene editing and next generation sequencing
5.1.3.2. Rising R&D funding and investments for expansion of synthetic biology applications
5.1.4. Challenges
5.1.4.1. Constraints of synthetic biology in modularization and standardization of biological parts
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Synthetic Biology Market, by Tools
6.1. Introduction
6.2. DNA Tools
6.3. General Tools
6.4. Mathematical Modelling & Computer-aided Design Tools
6.5. Protein Tools
6.6. RNA Tools
7. Synthetic Biology Market, by Technology
7.1. Introduction
7.2. Bioinformatics
7.3. Cell Sequencing
7.4. Cell Synthesis & Assembly
7.5. Cloning
7.6. Microfluidics
7.7. Nanotechnology
7.8. Omics Technologies
7.9. Site-directed Mutagenesis
8. Synthetic Biology Market, by End-Use
8.1. Introduction
8.2. Agriculture
8.3. Cosmetics & Personal Care
8.4. Energy & Natural Resources
8.5. Environment
8.6.1. Bioremediation
8.6.2. Biosensing
8.6. Food & Beverage
8.7. Healthcare & Pharmaceuticals
8.8.1. Artificial Tissue & Tissue Regeneration
8.8.2. Drug Discovery & Therapeutics
8.8. Paper & Textile
9. Americas Synthetic Biology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Synthetic Biology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Synthetic Biology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Moderna, Becoming A Buyer, Acquires A Synthetic Biology Specialist.
12.3.1.2. Ginkgo To Acquire Synbio Competitor Zymergen.
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Asimov Partners With IGEM To Support The Next Generation of Synthetic Biologists.
12.3.3. New Product Launch & Enhancement
12.3.3.1. NREL Launches Synthetic Biology Project To Advance Biofuel Discovery Technologies With LanzaTech, Northwestern, and Yale.
12.3.3.2. Tierra Biosciences Launches ‘proteins-On-Demand’ Platform To Speed Up Synbio Engineering.
12.3.4. Investment & Funding
12.3.4.1. Synthetic Biology Startup D-Nome Raises USD 1.5 Million In Funding From Ankur Capital, Campus Fund.
12.3.4.2. Northwestern and MIT Receive Funding From Army’s Synthetic Biology Center.
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Agilent Technologies, Inc.
13.1.2. Amyris, Inc.
13.1.3. Arzeda
13.1.4. Batavia Biosciences B.V.
13.1.5. Beam Therapeutics
13.1.6. Beckman Coulter, Inc.
13.1.7. BGI Genomics Co., Ltd.
13.1.8. Codexis, Inc.
13.1.9. Conagen, Inc.
13.1.10. Creative Enzymes
13.1.11. DNA TwoPointO Inc.
13.1.12. Editas Medicine, Inc.
13.1.13. Eurofins Scientific
13.1.14. GenScript Biotech Corporation
13.1.15. Ginkgo Bioworks, Inc.
13.1.16. Illumina, Inc.
13.1.17. Integrated DNA Technologies, Inc.
13.1.18. Merck KGaA
13.1.19. New England Biolabs GmbH
13.1.20. Novozymes A/S
13.1.21. Precigen, Inc.
13.1.22. QIAGEN N.V.
13.1.23. Sangamo Therapeutics
13.1.24. Scarab Genomics, LLC
13.1.25. Synlogic
13.1.26. Synthego Corporation
13.1.27. TeselaGen Service
13.1.28. Thermo Fisher Scientific Inc.
13.1.29. Twist Bioscience Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. SYNTHETIC BIOLOGY MARKET RESEARCH PROCESS
FIGURE 2. SYNTHETIC BIOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SYNTHETIC BIOLOGY MARKET DYNAMICS
FIGURE 7. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
FIGURE 8. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us